Dietary Flavonoids Alleviate Inflammation and Vascular Endothelial Barrier Dysfunction Induced by Advanced Glycation End Products In Vitro

The aim of this study was to compare the protective effects of three dietary flavonoids (apigenin-7-O-glucoside (A7G), isorhamnetin-3-O-rutinoside (I3R), and cyanidin-3-O-glucoside (C3G)) on advanced glycation end products (AGEs)-induced inflammation and vascular endothelial dysfunction. Furthermore, the potential mechanisms of varied effects of those three dietary flavonoids were analyzed by molecular docking analysis. Results showed that C3G (40 mu M) achieved the best inhibition on inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) in AGEs-induced RAW264.7 cells, followed by I3R, and A7G was the weakest. The molecular docking results also showed that C3G exhibited the closest binding with the receptor for AGE. However, I3R (40 mu M) demonstrated the best effect in improving endothelial dysfunction in AGEs-induced EA.hy926 cells, followed by C3G, and A7G was the weakest, as evidenced by the molecular docking results of flavonoids with profilin-1. This work may provide knowledge and helpful suggestions regarding the benefits of dietary flavonoids in diabetic vascular complications.

Automated summary

This study aimed to compare the protective effects of three dietary flavonoids (A7G, I3R, and C3G) on AGEs-induced inflammation and vascular endothelial dysfunction, and analyzed the potential mechanisms using molecular docking analysis. Results showed that C3G had the best inhibition on inflammatory cytokines, while I3R had the best effect in improving endothelial dysfunction. This study provides knowledge and suggestions regarding the benefits of dietary flavonoids in diabetic vascular complications.